Franklin Equity reported on February 16 that, following a protracted period of uncertainty in the previous year, the ...
The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...
AV Laboratories is redefining the future of skincare by translating decades of advanced biotechnology research into clinically driven formulations designed for everyday use. Rooted in expertise ...
Add Yahoo as a preferred source to see more of our stories on Google. Lululemon launched its first product using plant-based nylon in April 2023 Biotechnology is the exploitation of biological ...
StockStory.org on MSN
Biotechnology stocks Q3 results: Benchmarking Natera (NASDAQ:NTRA)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the 10 Best Small-Cap Biotech Stocks According to Hedge Funds. The stock’s ...
Debut Biotech, a company innovating new molecules, is partnering with Image Skincare to launch a new beauty product, CNBC has learned. The San Diego-based company uses biotechnology and artificial ...
Arrowhead Pharmaceuticals could notch more gains as the biotechnology firm prepares to release data tied to clinical trials ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer – Updated Phase 1 ...
Columbia Daily Tribune on MSN
Missouri S&T plans new biochemistry bachelor’s degree
Missouri S&T’s proposed biochemistry program would combine lab research, data analysis and life sciences to meet growing ...
Zacks Investment Research on MSN
Should you invest in the iShares Biotechnology ETF (IBB)?
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results